← SynDRA
TESEVATINIB
SynDRA canonical compound SYN0038192 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | EGFR | EPHB4 | ERBB2 | FLT4 | KDR | SRC |
|---|
| Mechanism of action | EGFR inhibitor | VEGFR inhibitor |
|---|
All known targets
- EPHB4
- EGFR
- ERBB2
- FLT4
- KDR
- SRC
Mechanisms of action (all sources)
- EGFR INHIBITOR
- VEGFR inhibitor
- EPHB4 MODULATOR
Cross-references
Synonyms
- Xl-647
- EXEL-7647
- KD-019
- KD-020
- KD019
- XL647
- XL 647
- EXEL 7647
- UNII-F6XM2TN5A1
- KD 019
- F6XM2TN5A1
- 7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
- Tesevatinib [USAN:INN]
- SCHEMBL721994
- SCHEMBL721993
- SCHEMBL721992
- C24H25Cl2FN4O2
- GTPL7944
- CHEMBL3544983
- EX-A172
- QCR-153
- MolPort-044-724-458
- BCP23438
- ZINC38912363
- 2809AH
- AKOS027255007
Look up TESEVATINIB in the interactive SynDRA portal →